Patterns of AKT, mTOR, ERK, and STAT3 pathway activation in MGUS, smoldering multiple myeloma, and multiple myeloma.

被引：0
|
作者：
Larsen, Jeremy Todd [1 ]
Ramakrishnan, Vijay [1 ]
Wellik, Linda [1 ]
Kimlinger, Teresa K. [1 ]
Rajkumar, S. Vincent [1 ]
Kumar, Shaji [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8589
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Panobinostat Inhibits JAK2/STAT3 Pathway in Multiple Myeloma.
    Perrone, Giulia
    Calabrese, Elisabetta
    Hideshima, Teru
    Gorgun, Gullu
    Hiroshi, Ikeda
    Cristea, Diana
    Santo, Loredana
    Hu Yiguo
    Anderson, Kenneth C.
    [J]. BLOOD, 2009, 114 (22) : 1113 - 1113
  • [2] The molecular basis of the transition of MGUS to multiple myeloma.
    Davies, FE
    Dring, AM
    Cheng, L
    Rawstron, AC
    Shammas, M
    Hideshima, T
    Chauhan, D
    Tai, IT
    Auclair, D
    Robinson, E
    Wong, WH
    Munshi, NC
    Morgan, GJ
    Anderson, KC
    [J]. BLOOD, 2002, 100 (11) : 102A - 102A
  • [3] Modeling the risk of progression in smoldering multiple myeloma.
    Waxman, Adam J.
    Mick, Rosemarie
    Garfall, Alfred L.
    Cohen, Adam D.
    Vogl, Dan T.
    Stadtmauer, Edward Allen
    Weiss, Brendan M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] AKT kinase addiction in multiple myeloma.
    Bardeleben, Carolyne
    Yan, Huajun
    Frost, Patrick
    Hoang, Bao
    Shi, Yijiang
    Sharma, Sanjai
    Lichtenstein, Alan
    [J]. BLOOD, 2006, 108 (11) : 979A - 980A
  • [5] MGUS: Comparison of patients who converted to multiple myeloma.
    Stanisic, S
    Saluan, MA
    McLain, D
    Cakulev, I
    Rybicki, L
    Hussein, MA
    [J]. BLOOD, 1998, 92 (10) : 271B - 271B
  • [6] Blockage of the JAK/STAT3 signaling pathway in multiple myeloma by leelamine
    Jung, Young Yun
    Um, Jae-Young
    Nasif, Omaima
    Alharbi, Sulaiman Ali
    Sethi, Gautam
    Ahn, Kwang Seok
    [J]. PHYTOMEDICINE, 2021, 87
  • [7] EZH2 Promotes Multiple Myeloma Progression via STAT3 Pathway Activation
    Wang, Yanyu
    Tian, Jing
    Huang, Dan
    Gao, Yuan
    Lin, Huan
    Liu, Lejia
    Wang, Aixin
    [J]. DISCOVERY MEDICINE, 2024, 36 (183) : 721 - 729
  • [8] Activation of stat3 and down-regulation of p27 are associated with the neoplastic phenotype in multiple myeloma.
    Moscinski, LC
    Mora, L
    El Eweis, I
    Hill, B
    Dalton, WS
    Jove, R
    [J]. BLOOD, 2002, 100 (11) : 805A - 805A
  • [9] Serum syndecan (CD138) levels are increased in patients with symptomatic multiple myeloma compared to normal controls, MGUS, and smoldering myeloma.
    Kumar, S
    Ahmann, G
    Witzig, TE
    Kyle, RA
    Greipp, PR
    [J]. BLOOD, 2002, 100 (11) : 806A - 807A
  • [10] Genomic patterns of progression in smoldering multiple myeloma
    Niccolò Bolli
    Francesco Maura
    Stephane Minvielle
    Dominik Gloznik
    Raphael Szalat
    Anthony Fullam
    Inigo Martincorena
    Kevin J. Dawson
    Mehmet Kemal Samur
    Jorge Zamora
    Patrick Tarpey
    Helen Davies
    Mariateresa Fulciniti
    Masood A. Shammas
    Yu Tzu Tai
    Florence Magrangeas
    Philippe Moreau
    Paolo Corradini
    Kenneth Anderson
    Ludmil Alexandrov
    David C. Wedge
    Herve Avet-Loiseau
    Peter Campbell
    Nikhil Munshi
    [J]. Nature Communications, 9
12345